COVID-19 vaccines and vaccination: how prepared is Africa?
COVID-19 vaccines and vaccination: how prepared is Africa?
复制标题
DOI：
10.11604/pamj.2021.39.107.27912
复制
发表时间：
2021
期刊：
影响因子：
--
通讯作者：
Olomojobi F
中科院分区：
文献类型：
--
作者：
Ariyo OE;Oladipo EK;Osasona OG;Obe O;Olomojobi F
紧急使用疫苗的批准标志着结束COVID-19大流行的一个重要里程碑。然而，在非洲接种的疫苗不到全球疫苗的2%，这使得非洲大陆处于一种不稳定的境地，可能会出现另一波可能消耗其卫生系统的浪潮。在疫苗民族主义面前，非洲仍然面临着巨大的任务。在大多数国家，疫苗的采购和部署都不是最理想的。在实现全球群体免疫的竞赛中将非洲排除在外可能是灾难性的。利益攸关方必须继续参与，以确保在非洲大陆成功部署疫苗。有必要在非洲建立快速研制和长期部署疫苗的能力。
The approval of vaccines for emergency use signifies a great milestone to end the COVID-19 pandemic. However, less than 2% of the global vaccines have been administered in Africa, putting the continent in a precarious situation in the eventuality of another wave that may consume its health system. There is still an enormous task in Africa in the face of vaccine nationalism. In most countries, vaccine acquisition and deployment have been suboptimal. Leaving out Africa in the race to achieve global herd immunity may be catastrophic. Stakeholders must continue engagement to ensure a successful deployment of the vaccines on the continent. There is a need to build capacity in Africa for rapid vaccine development and deployment in the long term.